DPH 830 Module 1 Measuring Global Health and Its Burden Example

Counting What Matters: How Global Health Is Measured and Why Burden Estimates Shape Priorities

Student Name

Doctor of Public Health Program, Aspen University

DPH 830: Global Health

Instructor Name

Month Day, Year

Counting What Matters: How Global Health Is Measured and Why Burden Estimates Shape Priorities

Before a ministry of health, a donor or an international agency can decide where to invest, it needs to know which conditions cause the most death and disability, where and among whom. Global health measurement tries to answer those questions in comparable terms across more than 200 countries. This paper explains the main measures, how burden estimates are produced, what they have revealed and where their limits lie.

Mortality and Life Expectancy

The oldest measures count deaths. Crude and age-standardized death rates, infant and under-five mortality and maternal mortality ratios remain essential because they are simple and widely understood. Life expectancy at birth summarizes mortality across all ages into one number. Yet a population can live longer while spending more years in poor health, which mortality measures alone cannot show.

Health-Adjusted Measures

Health-adjusted life expectancy converts the years people are expected to live into equivalent years of full health. Disability-adjusted life years, or DALYs, go further by adding two components for each condition: years lost through early death and years spent living with illness or impairment, weighted by severity. Each DALY equals a single year of healthy life lost, allowing deaths and nonfatal illness to be compared on one scale.

Comparing the Measures

The table compares six measures used in global health.

The Global Burden of Disease Study

The Global Burden of Disease Study began in the early 1990s with work for the World Bank and introduced the DALY to compare conditions on a common scale. Over 30 years it grew into a network of thousands of collaborators producing annual estimates by cause, age, sex, location and year, and it now informs national planning as well as global agendas (Murray, 2022).

What the 2019 Estimates Showed

The 2019 round covered 369 causes of illness and injury across 204 nations and territories. It found that the share of global DALYs due to noncommunicable diseases rose from about 43% in 1990 to about 64% in 2019, while communicable, maternal, neonatal and nutritional conditions declined. Burden from conditions of older age, such as ischemic heart disease, stroke and diabetes, grew rapidly (Vos et al., 2020).

The Epidemiological Transition

These shifts reflect an epidemiological transition. As child deaths from infection fall and populations age, chronic diseases and disability account for more of the burden. The transition is uneven. Many low-income countries now face a double burden, with infections and undernutrition persisting alongside rising hypertension, diabetes and cancer, stretching health systems built mainly for acute care.

Where the Data Come From

Estimates draw on vital registration systems, censuses, household surveys such as demographic and health surveys, disease registries, hospital records and published studies. Many countries lack complete registration of deaths and their causes, so estimators rely on verbal autopsy, in which trained interviewers ask families about symptoms before death, and on statistical models that borrow strength across places and years.

Uncertainty

Because data are incomplete, every estimate carries an uncertainty interval. Intervals are wide where data are sparse, often in the countries with the greatest burden. Users should report intervals, avoid ranking conditions whose intervals overlap heavily and treat modeled numbers as best estimates rather than counts. Reporting the interval alongside the point estimate is a sign of good practice in any paper that uses burden data.

Critiques of the DALY

The DALY has been criticized on several grounds. Disability weights reflect judgments about the severity of conditions and may not match the experiences of people living with them. Early versions weighted years lived at different ages differently and discounted future years; later rounds dropped age weighting. Critics also note that DALYs measure health loss, not the social and economic consequences of illness for families.

Burden Is Not Priority

A large burden does not by itself justify investment. Priority setting also asks whether effective, affordable interventions exist, whether the health system can deliver them well and what equity considerations apply. Poor quality matters as much as access: an analysis for a global commission estimated that of about 8.6 million deaths a year in low- and middle-income countries from conditions treatable by health care, 5.0 million were among people who used services of poor quality (Kruk et al., 2018).

Using Estimates in a Ministry

A ministry of health might use burden estimates to identify its top ten causes of DALYs, compare them with regional peers, check which have cost-effective interventions not yet at scale and examine subnational variation. The estimates start the conversation; local data, community input and budget realities complete it. Sharing the analysis with district managers helps them see how their areas compare.

Local Data Still Matter

Global models cannot replace local measurement. Strengthening vital registration, cause-of-death certification and routine health information systems gives countries their own evidence and reduces reliance on modeled figures. Investment in these systems is itself a global health priority.

Risk Factor Estimates

Burden studies also attribute health loss to risk factors such as high blood pressure, tobacco, air pollution, high blood sugar and child undernutrition. Attributable burden answers a different question from cause-specific burden: how much disease could be avoided if exposure were reduced. For prevention planning, risk factor rankings are often more useful than disease rankings, because one risk such as tobacco drives many conditions.

Equity Within Countries

National averages hide wide differences by region, income, ethnicity and sex. Subnational burden estimates, now produced for many large countries, show districts where child mortality is several times the national rate. Measurement that ignores these gaps can lead planners to invest where averages look worst rather than where need is greatest.

Communicating Burden

Numbers such as DALYs are unfamiliar to most policymakers. Translating them into plain comparisons, such as the share of healthy life lost to a condition or the number of deaths among children under five, helps. Visual tools that let users compare causes over time and across places have made burden estimates more accessible to ministries and journalists.

Conclusion

Global health measurement has moved from counting deaths to estimating healthy life lost across hundreds of conditions and places. The Global Burden of Disease Study shows a world shifting toward chronic disease while many countries still face infection and undernutrition. Used with attention to uncertainty, critiques and quality of care, burden estimates help decision makers focus resources where they can do the most good.

References

Kruk, M. E., Gage, A. D., Arsenault, C., Jordan, K., Leslie, H. H., Roder-DeWan, S., Adeyi, O., Barker, P., Daelmans, B., Doubova, S. V., English, M., García-Elorrio, E., Guanais, F., Gureje, O., Hirschhorn, L. R., Jiang, L., Kelley, E., Lemango, E. T., Liljestrand, J., ... Pate, M. (2018). High-quality health systems in the Sustainable Development Goals era: Time for a revolution. The Lancet Global Health, 6(11), e1196-e1252. https://doi.org/10.1016/S2214-109X(18)30386-3

Murray, C. J. L. (2022). The Global Burden of Disease Study at 30 years. Nature Medicine, 28(10), 2019-2026. https://doi.org/10.1038/s41591-022-01990-1

Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., Abdollahi, M., Abdollahpour, I., Abolhassani, H., Aboyans, V., Abrams, E. M., Abreu, L. G., Abrigo, M. R. M., Abu-Raddad, L. J., Abushouk, A. I., ... Murray, C. J. L. (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 396(10258), 1204-1222. https://doi.org/10.1016/S0140-6736(20)30925-9